Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat

Life Sciences

Volumn 62, Issue 15, 1998, Pages PL235-PL240

  Muscará, Marcelo N ^b   McKnight, Webb ^b   Del Soldato, Piero ^b   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

Cyclooxygenase; Hypertension; Nitric oxide; Nonsteroidal anti inflammatory drug

Indexed keywords

DRUG VEHICLE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NAPROXEN DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HYPERTENSION; INFLAMMATION; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SODIUM RETENTION; STOMACH MUCOSA LESION;

ANIMALIA;

EID: 0008915459     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00072-1     Document Type: Article

References (29)

1. 1. C. PATRONO and M.J. DUNN, Kidney Int. 32 1-2 (1987).
2. 2. J.A. OATES, G.A. FITZGERALD, R.A. BRANCH, E.K. JACKSON, H.R. KNAPP and L.J. ROBERTS, New Eng. J. Med. 319 761-767 (1988).
3. 3. K. ABE, Clin. Endocrinol. Metab. 10 577-605 (1981).
4. 4. J.G. GERBER, Ann. Intern. Med. 99 555-558 (1983).
5. 5. J.E. POPE, J.J. ANDERSON, D.T. FELSON, Arch. Intern. Med. 153 477-484 (1993).
6. 6. M.C. HOUSTON, Am. J. Med. 90 (suppl. 5A) 42S-47S (1991).
7. 7. J.L. WALLACE, Can. J. Gastroenterol. 10 451-459 (1996).
8. 8. F. MURAD, C. MITTAL, W. ARNOLD and S. KATSUKI, Adv. Cyclic Nucleotide Res. 9 145-158 (1978).
9. 9. L. IGNARRO, R. BYRNS, G. BUGA and K. WOOD, Circ. Res. 61 866-879 (1987).
10. 10. R. PALMER, A. FERRIGE and S. MONCADA, Nature 327 524-526 (1987).
11. 11. M.W. RADOMSKI, R.M.J. PALMER and S. MONCADA, Br. J. Pharmacol. 92 639-646 (1987).
12. 12. R. BHARDWAJ, C. PAGE, G. MAY and P. MOORE, Eur. J. Pharmacol. 157 83-89 (1988).
13. 13. P. KUBES, M. SUZUKI and D.N. GRANGER, Proc. Natl. Acad. Sci. USA 88 4651-4655 (1991).
14. 14. J.L. WALLACE, B. REUTER, C. CICALA, W. McKNIGHT, M.B. GRISHAM and G. CIRINO, Gastroenterology 107 173-179 (1994).
15. 15. J.L. WALLACE, B. REUTER, C. CICALA, W. McKNIGHT, M. GRISHAM and G. CIRINO, Eur. J. Pharmacol. 257 249-255 (1994).
16. 16. N.M. DAVIES, A.G. ROSETH, C.B. APPLEYARD, W. McKNIGHT, P. DEL SOLDATO, A. CALIGNANO, G. CIRINO and J.L. WALLACE, Aliment. Pharmacol. Ther. 11 69-79 (1997).
17. 17. J.L. WALLACE, W. McKNIGHT, P. DEL SOLDATO, A.R. BAYDOUN and G. CIRINO, J. Clin. Invest. 96 2711-2718 (1995).
18. 18. R. ZATZ, Lab. Anim. Sci. 42 198-201 (1990).
19. 19. J.L. WALLACE and B.J.R. WHITTLE, Eur. J. Pharmacol. 115 45-52 (1985).
20. 20. M.O. RIBEIRO, E. ANTUNES, G. DE NUCCI, S.M. LOVISOLO and R. ZATZ, Hypertension 20 298-303 (1992).
21. 21. C. BAYLIS, B. MITRUKA and A. DENG, J. Clin. Invest. 90 278-281 (1992).
22. 22. H. SHIMOKAWA and P.M. VANHOUTTE Circ. Res. 64 900-914 (1989).
23. 23. H. SHIMOKAWA and P.M. VANHOUTTE Am. Coll. Cardiol. 13 1402-1408 (1989).
24. 24. D.D. KU, Science, 218 576-578 (1982).
25. 25. V. LAHERA, M.G. SALOM, F. MIRANDA-GUARDIOLA, S. MONCADA and J.C. ROMERO, Am. J. Physiol. 261 F1033-F1037 (1991).
26. 26. C.E. WALDER, C. THIEMERMANN and J.R. VANE, Br. J. Pharmacol. 107 476-480 (1992).
27. 27. E.P. GREENBLATT, A.L. LOEB and D.E. LONGNECKER, J. Cardiovasc. Pharmacol. 21 235-240(1993).
28. 28. J.L. WALLACE AND A.W. TIGLEY, Aliment. Pharmacol. Ther. 9 227-235 (1995).
29. 29. REUTER, G. CIRINO and J.L, WALLACE, Life Sci. 55 PL1-8 (1994).